Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04900220 · ClinicalTrials.gov registry record · Phase 4
Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections
A Phase 4 study, sponsored by West Virginia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT04900220 is a Phase 4 study that has completed, run by West Virginia University. The registered enrollment target is 66 participants.
The verdict
NCT04900220, a Phase 4 study, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
Two common corticosteroids used for trigger finger treatment are betamethasone and methylprednisolone. Both injections are effective in treating trigger finger and the decision of which to use in treatment is currently a matter of the current practice and physician preference. The goal through this randomized trial is to see whether there is a difference between these two corticosteroids in inducing flare reactions and if there are any differences in the peak level of pain and their duration. Findings indicating a statistically significant difference in the incidence and/or intensity of the flare reactions would be clinically significant and would be evidence supporting the switch of current practice to one corticosteroid over the other.
Interventions
- DRUG Methylprednisolone
- DRUG Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2023-04-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04900220
The ClinicalTrials.gov registry entry for NCT04900220 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylprednisolone is the first listed.
NCT04900220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04900220 about?
NCT04900220 is a clinical study titled "Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections". Two common corticosteroids used for trigger finger treatment are betamethasone and methylprednisolone. Both injections are effective in treating trigger finger and the decision of which to use in treatment is currently a matter of the current practice and physician preference. The goal through this ...
What is the current status of trial NCT04900220?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2021-09-15. Estimated completion is 2023-04-10.
What interventions are being tested in trial NCT04900220?
The interventions under investigation include: Methylprednisolone (DRUG), Betamethasone (DRUG).
Who is sponsoring clinical trial NCT04900220?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.